Sumitomo Mitsui DS Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $31.5M | Sell |
63,330
-492
| -0.8% | -$218K | 0.22% | 90 |
|
|
2026
Q1 | $28.5M | Buy |
63,822
+1,061
| +2% | +$495K | 0.23% | 89 |
|
|
2025
Q4 | $28.5M | Buy |
62,761
+7,767
| +14% | +$3.35M | 0.22% | 89 |
|
|
2025
Q3 | $21.5M | Buy |
54,994
+6,904
| +14% | +$2.89M | 0.17% | 109 |
|
|
2025
Q2 | $21.4M | Buy |
48,090
+1,726
| +4% | +$795K | 0.19% | 99 |
|
|
2025
Q1 | $22.5M | Buy |
46,364
+695
| +2% | +$324K | 0.23% | 82 |
|
|
2024
Q4 | $18.4M | Buy |
45,669
+2,036
| +5% | +$944K | 0.19% | 96 |
|
|
2024
Q3 | $20.3M | Buy |
43,633
+889
| +2% | +$427K | 0.22% | 88 |
|
|
2024
Q2 | $20M | Buy |
42,744
+1,130
| +3% | +$490K | 0.24% | 80 |
|
|
2024
Q1 | $17.4M | Buy |
41,614
+1,302
| +3% | +$550K | 0.22% | 89 |
|
|
2023
Q4 | $16.4M | Buy |
40,312
+1,914
| +5% | +$707K | 0.21% | 100 |
|
|
2023
Q3 | $13.4M | Buy |
38,398
+1,324
| +4% | +$463K | 0.21% | 90 |
|
|
2023
Q2 | $13M | Buy |
37,074
+14,687
| +66% | +$4.95M | 0.2% | 95 |
|
|
2023
Q1 | $7.05M | Buy |
22,387
+1,277
| +6% | +$383K | 0.13% | 142 |
|
|
2022
Q4 | $6.1M | Sell |
21,110
-2,203
| -9% | -$671K | 0.12% | 147 |
|
|
2022
Q3 | $6.75M | Buy |
23,313
+1,736
| +8% | +$499K | 0.15% | 123 |
|
|
2022
Q2 | $6.08M | Buy |
21,577
+166
| +0.8% | +$44.4K | 0.15% | 124 |
|
|
2022
Q1 | $5.59M | Sell |
21,411
-404
| -2% | -$95.9K | 0.12% | 151 |
|
|
2021
Q4 | $4.79M | Buy |
21,815
+1,047
| +5% | +$204K | 0.1% | 183 |
|
|
2021
Q3 | $3.77M | Sell |
20,768
-151
| -0.7% | -$29.5K | 0.09% | 205 |
|
|
2021
Q2 | $4.22M | Buy |
20,919
+21
| +0.1% | +$4.39K | 0.1% | 187 |
|
|
2021
Q1 | $4.49M | Buy |
20,898
+983
| +5% | +$216K | 0.12% | 173 |
|
|
2020
Q4 | $4.71M | Buy |
19,915
+1,170
| +6% | +$268K | 0.13% | 152 |
|
|
2020
Q3 | $5.1M | Buy |
18,745
+447
| +2% | +$123K | 0.16% | 112 |
|
|
2020
Q2 | $5.31M | Buy |
18,298
+2,309
| +14% | +$626K | 0.18% | 106 |
|
|
2020
Q1 | $3.8M | Sell |
15,989
-25
| -0.2% | -$5.74K | 0.16% | 126 |
|
|
2019
Q4 | $3.51M | Sell |
16,014
-77
| -0.5% | -$15.6K | 0.12% | 174 |
|
|
2019
Q3 | $2.73M | Buy |
16,091
+2,234
| +16% | +$395K | 0.1% | 212 |
|
|
2019
Q2 | $2.54M | Sell |
13,857
-4,210
| -23% | -$736K | 0.1% | 201 |
|
|
2019
Q1 | $3.32M | Buy |
18,067
+1,124
| +7% | +$208K | 0.05% | 256 |
|
|
2018
Q4 | $2.81M | Sell |
16,943
-750
| -4% | -$130K | 0.05% | 251 |
|
|
2018
Q3 | $3.41M | Sell |
17,693
-221
| -1% | -$39.4K | 0.05% | 261 |
|
|
2018
Q2 | $3.04M | Buy |
17,914
+325
| +2% | +$50.4K | 0.05% | 287 |
|
|
2018
Q1 | $2.87M | Sell |
17,589
-886
| -5% | -$145K | 0.04% | 302 |
|
|
2017
Q4 | $2.77M | Sell |
18,475
-397
| -2% | -$58.8K | 0.04% | 312 |
|
|
2017
Q3 | $2.87M | Sell |
18,872
-1,126
| -6% | -$169K | 0.04% | 280 |
|
|
2017
Q2 | $2.58M | Sell |
19,998
-629
| -3% | -$75.7K | 0.04% | 307 |
|
|
2017
Q1 | $2.25M | Buy |
20,627
+1,953
| +10% | +$172K | 0.04% | 322 |
|
|
2016
Q4 | $1.38M | Sell |
18,674
-178
| -0.9% | -$14.5K | 0.03% | 382 |
|
|
2016
Q3 | $1.64M | Sell |
18,852
-52
| -0.3% | -$4.91K | 0.04% | 346 |
|
|
2016
Q2 | $1.63M | Buy |
18,904
+759
| +4% | +$65.6K | 0.05% | 301 |
|
|
2016
Q1 | $1.44M | Buy |
18,145
+222
| +1% | +$20.1K | 0.04% | 309 |
|
|
2015
Q4 | $2.25M | Sell |
17,923
-234
| -1% | -$28.2K | 0.08% | 222 |
|
|
2015
Q3 | $1.89M | Sell |
18,157
-444
| -2% | -$57K | 0.06% | 252 |
|
|
2015
Q2 | $2.3M | Sell |
18,601
-529
| -3% | -$66.7K | 0.07% | 241 |
|
|
2015
Q1 | $2.26M | Sell |
19,130
-932
| -5% | -$112K | 0.07% | 259 |
|
|
2014
Q4 | $2.38M | Sell |
20,062
-1,964
| -9% | -$221K | 0.07% | 250 |
|
|
2014
Q3 | $2.47M | Sell |
22,026
-2,168
| -9% | -$206K | 0.08% | 244 |
|
|
2014
Q2 | $2.29M | Sell |
24,194
-926
| -4% | -$64.9K | 0.07% | 279 |
|
|
2014
Q1 | $1.78M | Sell |
25,120
-1,339
| -5% | -$106K | 0.05% | 328 |
|
|
2013
Q4 | $1.97M | Sell |
26,459
-752
| -3% | -$52.4K | 0.06% | 299 |
|
|
2013
Q3 | $2.06M | Buy |
27,211
+590
| +2% | +$46.9K | 0.06% | 286 |
|
|
2013
Q2 | $2.13M | Buy |
+26,621
| New | +$1.96M | 0.06% | 284 |
|
Other funds holding VRTX
Sumitomo Mitsui DS Asset Management's VRTX Position: Q2 2026 in Review
Sumitomo Mitsui DS Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 0.77% in Q2 2026, selling an estimated $218K and leaving 63,330 shares worth $31.5M. The position accounts for 0.22% of the portfolio, ranked #90.
Sumitomo Mitsui DS Asset Management first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Sumitomo Mitsui DS Asset Management held 63,330 shares of Vertex Pharmaceuticals worth $31.5M as of Q2 2026.
- Sumitomo Mitsui DS Asset Management sold 492 Vertex Pharmaceuticals shares in Q2 2026, an estimated $218K.
- Vertex Pharmaceuticals made up 0.22% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #90 holding.
- Sumitomo Mitsui DS Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.